Cargando…
Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
To find new anti-browning and whitening agents in this study, new series of isopropylquinazolinone derivatives were designed and synthesized. All derivatives were evaluated as possible tyrosinase inhibitors and compound 9q bearing 4-fluorobenzyl moieties at the R position exhibited the best potencie...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290372/ https://www.ncbi.nlm.nih.gov/pubmed/37353836 http://dx.doi.org/10.1186/s13065-023-00978-3 |
_version_ | 1785062481910038528 |
---|---|
author | Hashemi, Arshia Noori, Milad Dastyafteh, Navid Sadat-Ebrahimi, Seyed Esmaeil Fazelzadeh Haghighi, Negin Mehrpour, Katayoun Sattarinezhad, Elahe Jalali Zafrei, Fatemeh Irajie, Cambyz Daneshmehr, Mohammad Ali Heydari, Majid Larijani, Bagher Iraji, Aida Mahdavi, Mohammad |
author_facet | Hashemi, Arshia Noori, Milad Dastyafteh, Navid Sadat-Ebrahimi, Seyed Esmaeil Fazelzadeh Haghighi, Negin Mehrpour, Katayoun Sattarinezhad, Elahe Jalali Zafrei, Fatemeh Irajie, Cambyz Daneshmehr, Mohammad Ali Heydari, Majid Larijani, Bagher Iraji, Aida Mahdavi, Mohammad |
author_sort | Hashemi, Arshia |
collection | PubMed |
description | To find new anti-browning and whitening agents in this study, new series of isopropylquinazolinone derivatives were designed and synthesized. All derivatives were evaluated as possible tyrosinase inhibitors and compound 9q bearing 4-fluorobenzyl moieties at the R position exhibited the best potencies with an IC(50) value of 34.67 ± 3.68 µM. The kinetic evaluations of 9q as the most potent derivatives recorded mix-type inhibition. Compounds 9o and 9q also exhibited potent antioxidant capacity with IC(50) values of 38.81 and 40.73 µM, respectively confirming their antioxidant potential. Molecular docking studies of 9q as the most potent derivative were exacuated and it was shown that quinazolinone and acetamide moieties of compound 9q participated in interaction with critical His residues of the binding site. The obtained results demonstrated that the 9q can be considered a suitable pharmacophore to develop potent tyrosinase inhibitors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-023-00978-3. |
format | Online Article Text |
id | pubmed-10290372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-102903722023-06-25 Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones Hashemi, Arshia Noori, Milad Dastyafteh, Navid Sadat-Ebrahimi, Seyed Esmaeil Fazelzadeh Haghighi, Negin Mehrpour, Katayoun Sattarinezhad, Elahe Jalali Zafrei, Fatemeh Irajie, Cambyz Daneshmehr, Mohammad Ali Heydari, Majid Larijani, Bagher Iraji, Aida Mahdavi, Mohammad BMC Chem Research To find new anti-browning and whitening agents in this study, new series of isopropylquinazolinone derivatives were designed and synthesized. All derivatives were evaluated as possible tyrosinase inhibitors and compound 9q bearing 4-fluorobenzyl moieties at the R position exhibited the best potencies with an IC(50) value of 34.67 ± 3.68 µM. The kinetic evaluations of 9q as the most potent derivatives recorded mix-type inhibition. Compounds 9o and 9q also exhibited potent antioxidant capacity with IC(50) values of 38.81 and 40.73 µM, respectively confirming their antioxidant potential. Molecular docking studies of 9q as the most potent derivative were exacuated and it was shown that quinazolinone and acetamide moieties of compound 9q participated in interaction with critical His residues of the binding site. The obtained results demonstrated that the 9q can be considered a suitable pharmacophore to develop potent tyrosinase inhibitors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-023-00978-3. Springer International Publishing 2023-06-23 /pmc/articles/PMC10290372/ /pubmed/37353836 http://dx.doi.org/10.1186/s13065-023-00978-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Hashemi, Arshia Noori, Milad Dastyafteh, Navid Sadat-Ebrahimi, Seyed Esmaeil Fazelzadeh Haghighi, Negin Mehrpour, Katayoun Sattarinezhad, Elahe Jalali Zafrei, Fatemeh Irajie, Cambyz Daneshmehr, Mohammad Ali Heydari, Majid Larijani, Bagher Iraji, Aida Mahdavi, Mohammad Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones |
title | Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones |
title_full | Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones |
title_fullStr | Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones |
title_full_unstemmed | Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones |
title_short | Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones |
title_sort | synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290372/ https://www.ncbi.nlm.nih.gov/pubmed/37353836 http://dx.doi.org/10.1186/s13065-023-00978-3 |
work_keys_str_mv | AT hashemiarshia synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT noorimilad synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT dastyaftehnavid synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT sadatebrahimiseyedesmaeil synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT fazelzadehhaghighinegin synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT mehrpourkatayoun synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT sattarinezhadelahe synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT jalalizafreifatemeh synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT irajiecambyz synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT daneshmehrmohammadali synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT heydarimajid synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT larijanibagher synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT irajiaida synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones AT mahdavimohammad synthesisandtyrosinaseinhibitoryactivitiesofnovelisopropylquinazolinones |